IPIRA Startups

IPIRA Startups

MaxiVio Inc.

Brief Description

MaxiVio, Inc. is building next‑generation light engines by uniting novel quantum materials with electron and photon structures in a highly integratable form. The foundational photonic solution for AI ecosystems offers a new class of light engines that merge quantum materials with advanced electron–photon engineering in an ultra‑integratable platform. This breakthrough unlocks AI‑driven wearables, creates seamless interfaces between the physical and digital worlds, and cuts the energy footprint of data‑intensive hyperscale computing.

Inventors

Peidong Yang, Maria...

Clarity Movement Co.

Brief Description

Clarity Movement Co. is a team of passionate engineers and scientists focused on making a positive impact in the world by tackling the global air pollution crisis. We leverage our expertise in air sensing technology, IoT devices, and data analytics to create solutions that empower communities to make more informed decisions and improve quality of life. Having already developed the world’s most accurate low-cost particulate matter sensor, Clarity is now deploying the next generation of dense air quality monitoring networks around the world to build smarter cities through...

BreezeBio

Brief Description

BreezeBio develops innovative therapies through targeted delivery of genetic medicines. The company's founders share the vision that recent scientific advancements in engineering CRISPR components and delivery vehicles offer a groundbreaking opportunity to develop safe and effective medicines for genetic diseases.

The company's proprietary Polymer nanoparticle can deliver CRISPR protein and gRNA. CRISPR in a protein form has many advantages, delivery has been a challenge limiting its application. To deliver CRISPR protein, encapsulation of CRISPR ribonucleoprotein...

Silicon Clocks, Inc.

Brief Description

Silicon Clocks was founded in 2006 to develop high performance semiconductor timing and sensor designs and its patented CMEMS technology. Silicon Clocks was backed by leading venture investors including Tallwood Venture Capital, Charles River Ventures, Formative Ventures, Lux Capital and Silicon Labs.

The company was co-founded by Dr. Roger Howe, former co-director of the Berkeley Sensor and Actuator Center and UC Berkeley Professor of Electrical Engineering, and BSAC post-doctoral researcher Emmanuel Quevy.

Silicon Clocks Inc. was...

nEye.ai

Brief Description

nEye.ai is a next-generation optical switch company. Their MEMS-based silicon photonics optical circuit switches (OCS) eliminate critical bottlenecks in AI processing by enabling direct optical connections among thousands of GPUs and memory units. The company's SuperSwitch is an ultra-low power consumption, high radix, compact chip-scale design, offering hyperscale data centers enhanced performance, efficiency, and scalability.

UC Berkeley Professor of Electrical Engineering and Computer Sciences, and Co-Director of Berkeley Sensor and Actuator Center and Berkeley...

Inapill

Brief Description

Inapill is developing novel therapeutics that tune immune cell metabolism (immunometabolism) to treat diseases caused by immune system overactivation and excessive inflammation.

The company was co-founded by Greg Timblin and Josh Farahzad. CEO Timblin earned his Ph.D. in Molecular & Cell Biology from UC Berkeley in 2014, in the labs of Professors Mark Schlissel and Robert Tjian. He also served as a postdoctoral fellow in Professor Kaoru Saijo’s lab at UC Berkeley, and then in Professor Val Weaver’s lab at UCSF.

Inventors

Kaoru Saijo, Greg Timblin...

Stylus Medicine

Brief Description

Stylus Medicine has created a new gene editing technology based on viral proteins called recombinases. These proteins naturally insert large swaths of DNA into bacterial genomes, but Stylus used machine learning to design recombinases that target specific regions of the human genome. The method is based on the pioneering work of Patrick Hsu, UC Berkeley assistant professor of bioengineering and co-founder and a core investigator of the Arc Institute. The company is on a mission to develop next-generation therapies for disease through genome engineering and chromatin...

EditPep, Inc.

Brief Description

CRISPR therapies enabled by a simple, potent delivery platform. The biotechnology company creates a class of peptides capable of delivering CRISPR enzymes into clinically-relevant and previously untransfectable cell types, enabling clients to get CRISPR therapies.

Inventors

Ross Wilson, Dana Foss, Alexander Marson, Srishti Sahu, David-Huy Nguyen, John Hunsinger, Daniel Carr

Company Founders

Dana Foss (UC Berkeley postdoc 2017-2022), UC Berkeley Assistant Adjunct Professor of Molecular Therapeutics Ross Wilson

Timeline 2021...

Two Blades Foundation

Brief Description

2Blades was established as a 501(c)3 charitable organization to implement practical uses of important innovations in plant science that address the rising incidence of crop disease. Working together with world leading scientists in plant-pathogen interactions, 2Blades has scouted and supported the most significant advances in the understanding of plant disease and immunity, as well as enabling technologies to develop disease resistant crops.

Remarkable advances have been realized in plant science over the past twenty years, including genome sequencing,...

QSX Bio

Brief Description

Developing medical therapeutics and vaccines through biosynthesis of natural compounds in plants.

Inventors

Jay Keasling, Yuzhong Liu, Henrik Scheller, Xiaoyue Chen, Samantha Aiko Crowe, James Reed, Laetitia Martin, Graham Arthur Hudson, Fei Gan

Company Founders

Yuzhong Liu

Timeline 2025. Company founded